COVID – Apothera

In Stock: Mounjaro 2.5mg Pre-Filled Pen SC Injection (Tirzepatide 2.5mg Pre-Filled Pen SC Injection)

By ApoThera April 3, 2023Blog

In Stock: Mounjaro 2.5 mg Injection (Click Here) 1) Weight Management Tirzepatide Once Weekly for the Treatment of Obesity | NEJM 2) Diabetes Mellitus, Type 2 Initial Dose – 2.5…

In Stock: Mounjaro 2.5mg Injection (Tirzepatide 2.5mg Injection)

By ApoThera March 30, 2023Blog

In Stock: Mounjaro 2.5mg Injection (Click Here) Weight Management Tirzepatide Once Weekly for the Treatment of Obesity | NEJM Diabetes Mellitus, Type 2 Initial Dose – 2.5 mg SC once…

In Stock: Mounjaro 2.5mg Injection (Tirzepatide 2.5mg Injection)

By ApoThera March 27, 2023Blog

In Stock: Mounjaro 2.5 mg Injection (Click Here) 1) Weight Management Tirzepatide Once Weekly for the Treatment of Obesity | NEJM 2) Diabetes Mellitus, Type 2 Initial Dose – 2.5…

In Stock: Mounjaro 5mg Injection (Tirzepatide 5mg Injection)

By ApoThera March 27, 2023Blog

In Stock: Mounjaro 5mg Injection 1) Weight Management Tirzepatide Once Weekly for the Treatment of Obesity | NEJM 2) Diabetes Mellitus, Type 2 Initial Dose – 2.5 mg SC once…

In Stock: Mounjaro 10mg Injection (Tirzepatide 10mg Injection)

By ApoThera March 27, 2023Blog

Available: Mounjaro 10mg Injection (Click Here) 1) Weight Management Tirzepatide Once Weekly for the Treatment of Obesity | NEJM 2) Diabetes Mellitus, Type 2 Initial Dose – 2.5 mg SC…

FDA Approves Lilly and Incyte’s OLUMIANT (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata

By ApoThera June 19, 2022Blog

Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT® (baricitinib), a once-daily pill, as a first-in-disease systemic treatment…

Drug Information for Paxlovid (Nirmatrelvir-Ritonavir), Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application

By ApoThera April 9, 2022Blog

Drug Info: ApoThera Drug Disease Clinical Support App Nirmatrelvir-Ritonavir (Paxlovid) - 300 mg nirmatrelvir + 100 mg Ritonavir by mouth twice daily x 5 days - Initiate as soon as…

In Stock: Mounjaro 2.5mg Pre-Filled Pen SC Injection (Tirzepatide 2.5mg Pre-Filled Pen SC Injection)

In Stock: Mounjaro 2.5mg Injection (Tirzepatide 2.5mg Injection)

In Stock: Mounjaro 2.5mg Injection (Tirzepatide 2.5mg Injection)

In Stock: Mounjaro 5mg Injection (Tirzepatide 5mg Injection)

In Stock: Mounjaro 10mg Injection (Tirzepatide 10mg Injection)

FDA Approves Lilly and Incyte’s OLUMIANT (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata

COVID-19 Variants

Put to the test: use of rapid testing technologies for covid-19

Timeline for COVID-19 Viral Load and Antibody Response (Rapid Antigen Testing and COVID-19 RT-PCR Testing)

Drug Information for Paxlovid (Nirmatrelvir-Ritonavir), Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application